| Bewertungen |
 |
|
|
| Neue Artikel |
|
|
|
|
|
Rezensionen zu:
Jakar, Verstellbar
Datum: Freitag, 23. November 2018
Autor: Gast
Rezension:
I can\'t get through at the moment seroquel xr coupons The privately-owned company based in Moscow has been granted rights to develop and commercialize olokizumab in all indications, but is pursuing RA. In September last year, UCB said subcutaneous olokizumab met the primary endpoint in a Phase IIb trial but discontinued internal development of the compound because the data suggested that olokizumab was \'merely\' comparable to Roche\'s already-marketed RoActemra/Actemra (tocilizumab); both of the humanised monoclonal antibodies target the IL-6 cytokine.
Bewertung:  |
|
|
|
| Warenkorb |
 |
|
| Sie haben noch keine Artikel in Ihrem Warenkorb. |
|
|
Kundengruppe:Gast
|
|
|
|
Dies ist nur eine Übergangsseite, in Kürze finden Sie hier eine neue Version
